NEW YORK (GenomeWeb) – The National Institutes of Health plans has awarded six clinical research institutions $43 million to create a National Human Genome Research Institute-led network that will use genomic medicine to investigate rare and undiagnosed diseases.

NHGRI said today the funding for the Undiagnosed Diseases Network, provided by the NIH Common Fund, expands the Undiagnosed Diseases Program that has been running at the NIH Clinical Center for six years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.